These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3325010)

  • 21. Risk of type 1 diabetes development in children with incidental hyperglycemia: A multicenter Italian study.
    Lorini R; Alibrandi A; Vitali L; Klersy C; Martinetti M; Betterle C; d'Annunzio G; Bonifacio E;
    Diabetes Care; 2001 Jul; 24(7):1210-6. PubMed ID: 11423504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there a relationship between islet cell surface antibodies and clinical, biochemical, hormonal, and immunogenetic parameters in newly diagnosed type I diabetics?
    Michaelis D; Rjasanowski I; Ratzmann KP; Strese J; Dietz H; Hildmann W
    Acta Biol Med Ger; 1982; 41(12):1093-8. PubMed ID: 6765149
    [No Abstract]   [Full Text] [Related]  

  • 23. Class II HLA Genotype Association With First-Phase Insulin Response Is Explained by Islet Autoantibodies.
    Koskinen MK; Lempainen J; Löyttyniemi E; Helminen O; Hekkala A; Härkönen T; Kiviniemi M; Simell O; Knip M; Ilonen J; Toppari J; Veijola R
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2870-2878. PubMed ID: 29300921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
    Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
    Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin secretion and immuno-genetic markers in diabetics with 'secondary failure' of oral hypoglycemic agents.
    Colman PG; Harrison LC; Tait BD
    Aust N Z J Med; 1985 Apr; 15(2):209-12. PubMed ID: 3896215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.
    Tuomi T; Björses P; Falorni A; Partanen J; Perheentupa J; Lernmark A; Miettinen A
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin autoantibodies in pre-diabetes.
    Riley WJ; Atkinson MA; MacLaren NK
    Adv Exp Med Biol; 1988; 246():45-51. PubMed ID: 3074667
    [No Abstract]   [Full Text] [Related]  

  • 28. Influence of age on insulin requirement in insulin dependent diabetes mellitus patients treated with CSII.
    Yamaguchi T; Kanatsuka A; Hashimoto N; Makino H; Yoshida S
    Horm Metab Res; 1986 Nov; 18(11):786-7. PubMed ID: 3539739
    [No Abstract]   [Full Text] [Related]  

  • 29. Correlation between islet cell antibodies and anti-cytomegalovirus IgM and IgG antibodies in healthy first-degree relatives of type 1 (insulin-dependent) diabetic patients.
    Nicoletti F; Scalia G; Lunetta M; Condorelli F; Di Mauro M; Barcellini W; Stracuzzi S; Pagano M; Meroni PL
    Clin Immunol Immunopathol; 1990 Apr; 55(1):139-47. PubMed ID: 2155076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Autoantibodies to the pancreatic islet cells in type-1 diabetes mellitus].
    Zlobina EN; Esenin VI; Demin IuM; Minkin SA
    Sov Med; 1988; (12):21-3. PubMed ID: 2468188
    [No Abstract]   [Full Text] [Related]  

  • 31. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-peptide: an index of insulin secretion.
    Faber OK; Binder C
    Diabetes Metab Rev; 1986; 2(3-4):331-45. PubMed ID: 3527619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients.
    Marner B; Agner T; Binder C; Lernmark A; Nerup J; Mandrup-Poulsen T; Walldorff S
    Diabetologia; 1985 Dec; 28(12):875-80. PubMed ID: 3912242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B-cell function and islet cell and other organ-specific autoantibodies in relatives to insulin-dependent diabetic patients.
    Nordén G; Jensen E; Stilbo I; Bottazzo GF; Lernmark A
    Acta Med Scand; 1983; 213(3):199-203. PubMed ID: 6342336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies.
    Bärmeier H; McCulloch DK; Neifing JL; Warnock G; Rajotte RV; Palmer JP; Lernmark A
    Diabetologia; 1991 Oct; 34(10):727-33. PubMed ID: 1959705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and significance of islet-cell autoantibodies in different types of diabetes mellitus.
    Del Prete GF; Betterle C; Padovan D; Erle G; Toffolo A; Bersahi G
    Diabetes; 1977 Oct; 26(10):909-15. PubMed ID: 332567
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chronic complications in adult patients with newly diagnosed diabetes mellitus in relation to the presence of humoral autoimmune markers against pancreatic islet cells].
    Szepietowska B; Szelachowska M; Górska M; Jakubczyk D; Kinalska I
    Pol Arch Med Wewn; 2004 May; 111(5):563-9. PubMed ID: 15508807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitus.
    Wilkin T; Hoskins PJ; Armitage M; Rodier M; Casey C; Diaz JL; Pyke DA; Leslie RD
    Lancet; 1985 Mar; 1(8427):480-1. PubMed ID: 2857852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic control and B cell function in patients with insulin-dependent diabetes mellitus secondary to chronic pancreatitis.
    Larsen S; Hilsted J; Tronier B; Worning H
    Metabolism; 1987 Oct; 36(10):964-7. PubMed ID: 3309547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspartic acid at position 57 of the HLA-DQ beta chain is protective against future development of insulin-dependent (type 1) diabetes mellitus.
    Boehm BO; Manfras B; Rosak C; Schöffling K; Trucco M
    Klin Wochenschr; 1991 Feb; 69(4):146-50. PubMed ID: 2041376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.